Delivery Order SPE2DB22D1106-SPE2DB24FDZV2
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,150.38, is for the delivery of Ropivacaine 0.5% 150 mg/30 ml, a local anesthetic medication, with a completion date of May 19, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. The $5,997.77 firm-fixed price delivery order has a completion date of November 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4566333296 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The contract has a ceiling value of $1,335.38 and is a firm-fixed price delivery order that runs through November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award, valued at $1,982.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564415866 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 29, 2024 and is a Firm Fixed Price Delivery Order. The contract was awarded on April 26, 2024 and is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,174.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,051.57 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml injectable medication. The award does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554735557 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The firm-fixed-price delivery order, valued at $10,088.92, has a completion date of September 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and operates as a for-profit...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Medical Supply Chain for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectables. The contract, identified as SPE2DX15D1053|SPE2DX24F6CZS, is a Firm Fixed Price Delivery Order with a ceiling value of $5,396.69 and a period of performance through November 27, 2023. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical...
- This federal contract award, identified as SPE2DB22D3016|SPE2DB24FAEC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,594.70, is for the delivery of Ropivacaine 0.2% 400 mg/200 mL medication. This is a Firm Fixed Price delivery order contract with an ultimate completion date of November 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medical products to the Defense Logistics Agency (DLA). The $4,945.34 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...